Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × regorafenib × Clear all

NCT02955940 2025-12-17

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

Phase 2 Active not recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02307500 2022-09-10

RESOUND

Phase 2 Completed

DermatologicGastrointestinalGynecologicSarcomaThoracic

Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Thymoma

NCT02080260 2022-04-21

A Study of Regorafenib in Advanced Pancreatic Cancer Patients

Phase 2 Completed

20 enrolled 19 charts

Gastrointestinal

Pancreatic Neoplasms